Announcements Trials
Browse Landscape

Status

Completed 5

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 13Observational 5

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 11Stomach Neoplasms 6Neoplasms 5Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Myositis 2Lung Neoplasms 2Cholangiocarcinoma 2Vascular Complications 1Sjogren's Syndrome 1Scleroderma, Systemic 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Plaque, Atherosclerotic 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Metastatic Colorectal Adenocarcinoma 1Melanoma 1Lupus Erythematosus, Systemic 1Lung Diseases, Interstitial 1Liver Neoplasms 1Influenza, Human 1Immune-Related Adverse Events 1Hypersensitivity 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Neoplasms × Immune Checkpoint Inhibitors × Clear all
NCT07593053 2026-05-22

PIPO

Vall d'Hebron Institute of Oncology

Completed
586 enrolled
Tumor-Agnostic

Neoplasms

NCT07192926 2026-02-20

SARCO-CTI

Ankara Etlik City Hospital

Completed
131 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT03868046 2025-04-01

AUTENTIC

Hospital Universitario Araba

Completed
242 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT05934214 2024-03-05

EXIT

Groupe Hospitalier Pitie-Salpetriere

Completed
141,630 enrolled
Tumor-Agnostic

Neoplasms

NCT03492242 2019-09-26

CHIMeRA

Groupe Hospitalier Pitie-Salpetriere

Completed
1,000 enrolled

Arthritis, Autoimmune Diseases, Endocrine System Diseases, Eye Diseases, Heart Diseases, Myositis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡